Main pageHealth JournalHealth NewsOzempic (Semaglutide), Wegovy (Semaglutide) | Application in Weight Loss

Ozempic (Semaglutide), Wegovy (Semaglutide) | Application in Weight Loss

Submit Comment

Views: 120283

Health News

Ozempic (Semaglutide), Wegovy (Semaglutide) | Application in Weight Loss

Share

icon
icon
icon
icon

Updated:

08 August 2023

Ideal weight has a direct relationship with an individual’s health. In the pursuit of weight loss and achieving an ideal body shape, many supplements and medications are encountered. Ozempic and Wegovy are two new supplements that have gained attention for weight loss. This article examines these two supplements, their effectiveness, risks, and purchasing options for Ozempic and Wegovy.

Is Semaglutide Safe and Effective?

Since 2014, weekly injections of 2.4 mg semaglutide have been approved by the U.S. FDA for managing weight in adults with chronic obesity and at least one condition such as high blood pressure, high cholesterol, or type 2 diabetes.

Ozempic Image

What is Ozempic?

Ozempic (semaglutide) is an injectable medication designed to improve blood sugar levels in type 2 diabetes patients. This weekly injectable drug is prescribed alongside proper diet and exercise to reduce the risk of events like stroke or heart attack. Ozempic is not applicable for type 1 diabetes.

How Does Ozempic Work?

Ozempic belongs to the GLP-1 (glucagon-like peptide-1) agonist drug category. It works by binding to GLP-1 receptors, helping the pancreas to stimulate insulin release when needed. Ozempic also reduces blood sugar released by the liver and slows down gastric emptying. These combined effects help lower blood sugar, reduce appetite, and promote weight loss and fitness.

What is the Difference Between Ozempic and Wegovy?

Both Ozempic and Wegovy are brand names containing the active ingredient semaglutide, differing in dosage. Wegovy is FDA-approved for weight loss, while Ozempic is approved for type 2 diabetes. Both medications require consultation with a doctor, but due to its significant weight loss effects, Ozempic is being used off-label among celebrities.

Contraindications for Ozempic

  • Patients with the rare condition "Multiple Endocrine Neoplasia (MEN)"
  • Personal or family history of thyroid cancer
  • Pregnant women

Ozempic Dosage

The dosage should be determined by a doctor. Typically, Ozempic is injected once weekly, with a maximum weekly dosage of 2.4 mg, which must be gradually increased. The starting dose is 0.25 mg weekly for 4 weeks. Starting with a high dose may cause side effects. If a dose is missed, take it as soon as remembered and return to the regular schedule. If more than 5 days have passed, take the next scheduled dose.

Side Effects of Ozempic

  • Low blood sugar (hypoglycemia)
  • Stomach discomfort, heartburn, and bloating
  • Nausea, vomiting, stomach pain, appetite loss
  • Diarrhea and constipation
  • Runny nose or sore throat
  • Headache, dizziness, and fatigue

Can Ozempic Be Purchased with Insurance?

Ozempic must be purchased out-of-pocket, as no insurance covers the cost.

References:

https://www.drugs.com/ozempic.html

https://www.drugs.com/victoza.html

https://www.healthline.com/health/drugs/ozempic-vs-victoza#ingredients

Get Consultation and In-Person Appointments from Related Doctors

Our Customers' Comments

No comments registered

logo
logo

PBmeds aims to be a comprehensive one-stop healthcare solution. By integrating prescription management, telemedicine consultations, and personalized healthcare support into a single platform, PBmeds offers users a seamless experience, eliminating the need to navigate multiple services for their healthcare needs. This all-in-one approach enhances convenience, improves user satisfaction, and positions the platform as a unique player in the Canadian digital health market.

Registration system for doctors and centers

Head Office: 701 West Georgia Street Pacific Centre, Suite 1500 Vancouver, BC

PBmeds support (from 9:00 am to 10:00 pm):

(438) 988-4884

All material and intellectual rights belong to Pardazesh Movazi Arya Company.